Followers | 3180 |
Posts | 208744 |
Boards Moderated | 2 |
Alias Born | 02/04/2004 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, August 10, 2017 12:21:07 PM
The only way that happens is if Dr. Odidi is willing to step aside and bring in a seasoned pro CEO to make that deal...while simultaneously freeing Dr. Odidi up to go all in on the science behind his novel nPODDS and PODRAS delivery tech platforms.
We already know from past presentations that Dr. Odidi has another 20 opioid based NDA's planned.
We already know from the ever changing landscape that the FDA screwed their entire generics pipeline from getting to market in a far more timely fashion anyways.
And we already know that the real money in IPCI's still evolving/emerging pipeline is in the opioid based NDA's and Dr. Odidi's nPODDS and PODRAS proprietary delivery tech platforms anyways.
There's a multitude of directions IPCI can go from here if Dr. Odidi's been humbled enough since the Rexista adcom rejection.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM